Wolfe Emerging Tech Forbes

Total Page:16

File Type:pdf, Size:1020Kb

Wolfe Emerging Tech Forbes INSIDE • Tony Atala: Building Better Body Parts • PW Singer: Waging War With Robots • Chip Clark: Vaccines To Vanquish Disease • Word On The Street • Emerging Tech Portfolio Forbes/Wolfe Emerging Tech Volume 10/ Number 5/ May 2011 www.forbesnanotech.com REPORT Tony Atala: Building Better Body Parts The Insider JOSH WOLFE, EDITOR r. Anthony Atala is director of the Wake Forest Institute for Regenerative Medi- obotic warfare, regrow- Dcine, where his work focuses on grow- ing organs, rapidly mak- ing and regenerating tissues and organs. He is Ring new vaccines: The also chair of the department of urology at the future is here, it's just unevenly Wake Forest University School of Medicine in distributed. And our three ex- North Carolina. His team engineered the first clusive interviews this month lab-grown organ to be implanted into a reveal three more clues to who human–a bladder–and is developing experi- your couriers of the future are. mental fabrication technology that can print We start with Tony Atala, human tissue on demand. In 2007, Atala and a the director of the Institute team of Harvard University researchers showed for Regenerative Medicine at that stem cells can be harvested from the amni- Wake Forest. His lab focuses otic fluid of pregnant women. This and other on growing organs from breakthroughs in the development of smart bio- blood vessels to bladders and materials and tissue fabrication technology beyond. Consider the impact promises to revolutionize the practice of medi- and implications of his cine. Atala was born in Peru in 1958 and grew breakthrough work on pa- up in Boca Raton, Florida. He obtained his un- tients who wait today on dis- dergraduate degree in psychology from the tressing donor lists for criti- University of Miami, and his medical degree TONY ATALA cal organs they need—and from the University of Louisville where he also imagine the ability to print completed his residency in urology. From 1990-1992, he trained under world-renowned pediatric urologic sur- Continued on page 2 geons Alan Retik and Hardy Hendren as a fellow at the Harvard Medical School affiliated Children's Hospital Boston. Continued on page 2 PW Singer: Chip Clark: Waging War Vaccines To With Robots Vanquish Disease eter Warren Singer is an author and sen- hip Clark is the chief executive offi- ior fellow and director of the 21st Cen- cer of Genocea Biosciences, a vaccine Ptury Defense Initiative at the Brookings Cdevelopment company based on a Institution. He is the youngest scholar named revolutionary platform for the rapid discov- senior fellow in Brookings's 90-year history. Dr. ery of antigens that induce T-cell immunity Singer’s most recent book, Wired for War (Pen- (Full disclosure: my venture firm Lux Capital PW SINGER guin, 2009), looks at the implications of robotics CHIP CLARK is an equity investor). Clark joins Genocea and other new Continued on page 4 with more than 20 Continued on page 6 Continued from page 1 The Insider Tony Atala: Building Better Body Parts Continued from page 1 nary areas with a common goal of achieving cartilage and skin tissues. and grow organs, like we print paper the regeneration of diseased or injured tissues or prototypes on 3D printers today. and organs. Could you walk through the process of It is this steady march of technol- how you grow a bladder outside the ogy and its healing potential that at- How old of a field is this? body? tracts talent and attention. But technol- The field really dates back to the early 1900s, We take a very small piece of tissue from the ogy's power also attracts talent and when people started thinking about the re- specific organ of interest within a patient–less attention, to both protect and destroy. placement of organs and creating tissues. than half the size of a postage stamp. Then we We speak with military and technol- Through the years it has taken on many dif- grow and extend these cells outside the body ogy expert PW Singer in an exclusive ferent names, including cell transplantation in large quantities. We are then able to create a and wide-ranging interview on the and tissue engineering. It’s finally come to- biomaterial that replicates the structural prop- complicated and quickly changing na- gether as a common area we now call regener- erties of the tissue or organ being replaced, ture of technology in combat and the ative medicine. and we coat or layer the cells onto this bioma- rapidly evolving way we wage war. PW terial, one layer at a time. Then, we are able to is the author of Wired for War (a dou- What were some of the early successes in place these cells and this material in a biore- ble entendre suggesting both our ma- the space? actor, which has the same conditions as the chines and ourselves) and discusses One of the very first applications of cells for human body. Finally, we are able to place that 21st century warfare and how robots regeneration of tissue dates back to 1981, functional tissue or organ back into the pa- are becoming as significant as gun- when a patient with a burn had a very small tient. In some ways, it’s very much like baking powder. As one friend says: it's our Sil- piece of normal skin taken, then grown out- a cake. icon versus their sons. side the body and subsequently placed over We also sit with Chip Clark, CEO the burn area. It did not regenerate the skin, So if you were to write a cookbook on of Genocea (full disclosure: my ven- but it did help the wound to heal faster, and growing an organ, what are the basic ture firm, Lux Capital is a founding in- that's the very first time that cells were used to ingredients required? vestor) who is fighting another kind of help to regenerate tissue. Since that time we’ve First you need a cell source. Then you need warfare: biological. Chip shares stories had to face many challenges in the field, some adequate biomaterial to create a struc- at the front lines of the fight against in- which involve how to get cells to effectively tural scaffold. Finally, you need sufficient vas- fectious disease and the quest to pro- grow outside the body, how to make sure cularity for blood flow. tect mankind from some of the worst these tissues function properly, and how to offenders by rapidly discovering and safely turn these cells into effective therapies Are you effectively trying to recreate the developing new vaccines. for patients. ecosystem of the body externally for cells As always, here's to thinking big to grow? about thinking small and to the Where are the researchers who are Absolutely. We try to replicate the normal emerging inventors and investors who pioneering this space coming from? conditions of the human body outside of the seek to profit from the unexpected and It’s interesting to see that every single major body. At the end of the day, as long as the cells the unseen. university has some activity in the area of are in the right environment, they know what stem cell biology or regenerative medicine at to do. this point. So it is definitely a growing field, and one that is benefiting from more investi- Over the last 30 years, what has been the gators joining the area. It's not just the biggest change in the field of U.S.–there are many countries where these ef- regenerative medicine? forts are being conducted. The U.S. benefits At a high level, we’ve transitioned from con- from the interactions that we have with our cept to practicality. We’ve come to prove that international colleagues. engineering of complex tissues is indeed pos- sible. We faced many challenges along the When was the first time you got way; the first was just the ability to grow cells Broadly, how would you describe the work introduced to the concept of regenerative outside of the body in large quantities–some- that you do? medicine? thing very hard to do several decades ago. The What we're working on is really the field of re- I'm a pediatric surgeon; I was looking at alter- second was vascularity–the ability to have generative medicine–trying to get cells and natives to the standard approaches for doing cells be fed with blood vessels so that they tissues to regenerate, so that we can help ac- surgery on children with congenital defects. I could survive a long time. The third was bio- celerate the delivery of these technologies to realized that probably the best option would materials–finding the right materials to use so patients. be to replace their diseased tissue with their we could actually engineer tissues that would own tissues that could be created outside the be biocompatible, and more importantly, What is regenerative medicine? body. The first thing we started working on function as they are supposed to. A science that involves many multi-discipli- was bladder tissue, and we also worked with 2 | MAY 2011 © COPYRIGHT 2011 FORBES/WOLFE EMERGING TECH REPORT Tony Atala: Building Better Body Parts Continued from page 2 ture in a rabbit model, and we were able to other types of organs like bladders, urethras "We’ve come to show that it functioned quite fully, to the point and blood vessels. The number of tissues that prove that where these rabbits could give rise to off- are currently being studied and that are being spring.
Recommended publications
  • WIKINOMICS How Mass Collaboration Changes Everything
    WIKINOMICS How Mass Collaboration Changes Everything EXPANDED EDITION Don Tapscott and Anthony D. Williams Portfolio Praise for Wikinomics “Wikinomics illuminates the truth we are seeing in markets around the globe: the more you share, the more you win. Wikinomics sheds light on the many faces of business collaboration and presents a powerful new strategy for business leaders in a world where customers, employees, and low-cost producers are seizing control.” —Brian Fetherstonhaugh, chairman and CEO, OgilvyOne Worldwide “A MapQuest–like guide to the emerging business-to-consumer relation- ship. This book should be invaluable to any manager—helping us chart our way in an increasingly digital world.” —Tony Scott, senior vice president and chief information officer, The Walt Disney Company “Knowledge creation happens in social networks where people learn and teach each other. Wikinomics shows where this phenomenon is headed when turbocharged to engage the ideas and energy of customers, suppli- ers, and producers in mass collaboration. It’s a must-read for those who want a map of where the world is headed.” —Noel Tichy, professor, University of Michigan and author of Cycle of Leadership “A deeply profound and hopeful book. Wikinomics provides compelling evidence that the emerging ‘creative commons’ can be a boon, not a threat to business. Every CEO should read this book and heed its wise counsel if they want to succeed in the emerging global economy.” —Klaus Schwab, founder and executive chairman, World Economic Forum “Business executives who want to be able to stay competitive in the future should read this compelling and excellently written book.” —Tiffany Olson, president and CEO, Roche Diagnostics Corporation, North America “One of the most profound shifts transforming business and society in the early twenty-first century is the rapid emergence of open, collaborative innovation models.
    [Show full text]
  • The Application Usage and Risk Report an Analysis of End User Application Trends in the Enterprise
    The Application Usage and Risk Report An Analysis of End User Application Trends in the Enterprise 8th Edition, December 2011 Palo Alto Networks 3300 Olcott Street Santa Clara, CA 94089 www.paloaltonetworks.com Table of Contents Executive Summary ........................................................................................................ 3 Demographics ............................................................................................................................................. 4 Social Networking Use Becomes More Active ................................................................ 5 Facebook Applications Bandwidth Consumption Triples .......................................................................... 5 Twitter Bandwidth Consumption Increases 7-Fold ................................................................................... 6 Some Perspective On Bandwidth Consumption .................................................................................... 7 Managing the Risks .................................................................................................................................... 7 Browser-based Filesharing: Work vs. Entertainment .................................................... 8 Infrastructure- or Productivity-Oriented Browser-based Filesharing ..................................................... 9 Entertainment Oriented Browser-based Filesharing .............................................................................. 10 Comparing Frequency and Volume of Use
    [Show full text]
  • Emerging Trends in Management, IT and Education ISBN No.: 978-87-941751-2-4
    Emerging Trends in Management, IT and Education ISBN No.: 978-87-941751-2-4 Paper 3 A STUDY ON REINVENTION AND CHALLENGES OF IBM Kiran Raj K. M1 & Krishna Prasad K2 1Research Scholar College of Computer Science and Information Science, Srinivas University, Mangalore, India 2 College of Computer Science and Information Science, Srinivas University, Mangalore, India E-mail: [email protected] Abstract International Business Machine Corporation (IBM) is one of the first multinational conglomerates to emerge in the US-headquartered in Armonk, New York. IBM was established in 1911 in Endicott, New York, as Computing-Tabulating-Recording Company (CTR). In 1924, CTR was renamed IBM. Big Blue has been IBM's nickname since 19 80. IBM stared with the production of scales, punch cards, data processors and time clock now produce and sells computer hardware and software, middleware, provides hosting and consulting services.It has a worldwide presence, operating in over 175 nations with 3,50,600 staff with $79. 6 billion in annual income (Dec 2018). It is currently competing with Microsoft, Google, Apple, and Amazon. 2012 to 2017 was tough time for IBM, although it invests in the field of research where it faced challenges while trying to stay relevant in rapidly changing Tech-Market. While 2018 has been relatively better and attempting to regain its place in the IT industry. With 3,000 scientists, it invests 7% of its total revenue to Research & Development in 12 laboratories across 6 continents. This resulted in the U.S. patent leadership in IBM's 26th consecutive year. In 2018, out of the 9,100 patents that granted to IBM 1600 were related to Artificial Intelligence and 1,400 related to cyber-security.
    [Show full text]
  • UNIT CONVERSION FACTORS Temperature K C 273 C 1.8(F 32
    Source: FUNDAMENTALS OF MICROSYSTEMS PACKAGING UNIT CONVERSION FACTORS Temperature K ϭ ЊC ϩ 273 ЊC ϭ 1.8(ЊF Ϫ 32) ЊR ϭ ЊF ϩ 460 Length 1 m ϭ 1010 A˚ ϭ 3.28 ft ϭ 39.4 in Mass 1 kg ϭ 2.2 lbm Force 1 N ϭ 1 kg-m/s2 ϭ 0.225 lbf Pressure (stress) 1 P ϭ 1 N/m2 ϭ 1.45 ϫ 10Ϫ4 psi Energy 1 J ϭ 1W-sϭ 1 N-m ϭ 1V-C 1Jϭ 0.239 cal ϭ 6.24 ϫ 1018 eV Current 1 A ϭ 1 C/s ϭ 1V/⍀ CONSTANTS Avogadro’s Number 6.02 ϫ 1023 moleϪ1 Gas Constant, R 8.314 J/(mole-K) Boltzmann’s constant, k 8.62 ϫ 10Ϫ5 eV/K Planck’s constant, h 6.63 ϫ 10Ϫ33 J-s Speed of light in a vacuum, c 3 ϫ 108 m/s Electron charge, q 1.6 ϫ 10Ϫ18 C SI PREFIXES giga, G 109 mega, M 106 kilo, k 103 centi, c 10Ϫ2 milli, m 10Ϫ3 micro, ␮ 10Ϫ6 nano, n 10Ϫ9 Downloaded from Digital Engineering Library @ McGraw-Hill (www.digitalengineeringlibrary.com) Copyright © 2004 The McGraw-Hill Companies. All rights reserved. Any use is subject to the Terms of Use as given at the website. Source: FUNDAMENTALS OF MICROSYSTEMS PACKAGING CHAPTER 1 INTRODUCTION TO MICROSYSTEMS PACKAGING Prof. Rao R. Tummala Georgia Institute of Technology ................................................................................................................. Design Environment IC Thermal Management Packaging Single Materials Chip Opto and RF Functions Discrete Passives Encapsulation IC Reliability IC Assembly Inspection PWB MEMS Board Manufacturing Assembly Test Downloaded from Digital Engineering Library @ McGraw-Hill (www.digitalengineeringlibrary.com) Copyright © 2004 The McGraw-Hill Companies.
    [Show full text]
  • Pluripotent Stem Cells: the Search for the "Perfect" Source
    Minnesota Journal of Law, Science & Technology Volume 12 Issue 2 Article 10 2011 Pluripotent Stem Cells: The Search for the "Perfect" Source Nancy M.P. King Christine Nero Coughlin Anthony Atala Follow this and additional works at: https://scholarship.law.umn.edu/mjlst Recommended Citation Nancy M. King, Christine N. Coughlin & Anthony Atala, Pluripotent Stem Cells: The Search for the "Perfect" Source, 12 MINN. J.L. SCI. & TECH. 715 (2011). Available at: https://scholarship.law.umn.edu/mjlst/vol12/iss2/10 The Minnesota Journal of Law, Science & Technology is published by the University of Minnesota Libraries Publishing. King NMP, Coughlin CN, Atala A. Pluripotent Stem Cells: The Search for the “Perfect” Source. Minnesota Journal of Law, Science & Technology. 2011;12(2):715-30. Pluripotent Stem Cells: The Search for the “Perfect” Source Nancy M.P. King*, Christine Nero Coughlin** & Anthony Atala*** Anyone who dreamed that the public controversy over human embryonic stem cell (hESC) research had begun to die down was rudely awakened by the decision in Sherley v. Sebelius.1 On August 23, District of Columbia District Court Judge Royce Lamberth issued a preliminary injunction halting federal funding of research using newly created hESC lines until the plaintiffs’ challenge to the 2009 liberalization of funding guidelines can be heard.2 On September 9, 2010, the Court of Appeals for the District of Columbia temporarily stayed Judge Lamberth’s order,3 and on September 28, 2010, the Court of Appeals ordered that the appeal be expedited and granted the Obama administration’s motion to permit federally © 2011 Nancy M.P.
    [Show full text]
  • DB2 10.5 with BLU Acceleration / Zikopoulos / 349-2
    Flash 6X9 / DB2 10.5 with BLU Acceleration / Zikopoulos / 349-2 DB2 10.5 with BLU Acceleration 00-FM.indd 1 9/17/13 2:26 PM Flash 6X9 / DB2 10.5 with BLU Acceleration / Zikopoulos / 349-2 00-FM.indd 2 9/17/13 2:26 PM Flash 6X9 / DB2 10.5 with BLU Acceleration / Zikopoulos / 349-2 DB2 10.5 with BLU Acceleration Paul Zikopoulos Sam Lightstone Matt Huras Aamer Sachedina George Baklarz New York Chicago San Francisco Athens London Madrid Mexico City Milan New Delhi Singapore Sydney Toronto 00-FM.indd 3 9/17/13 2:26 PM Flash 6X9 / DB2 10.5 with BLU Acceleration / Zikopoulos / 349-2 McGraw-Hill Education books are available at special quantity discounts to use as premiums and sales promotions, or for use in corporate training programs. To contact a representative, please visit the Contact Us pages at www.mhprofessional.com. DB2 10.5 with BLU Acceleration: New Dynamic In-Memory Analytics for the Era of Big Data Copyright © 2014 by McGraw-Hill Education. All rights reserved. Printed in the Unit- ed States of America. Except as permitted under the Copyright Act of 1976, no part of this publication may be reproduced or distributed in any form or by any means, or stored in a database or retrieval system, without the prior written permission of pub- lisher, with the exception that the program listings may be entered, stored, and exe- cuted in a computer system, but they may not be reproduced for publication. All trademarks or copyrights mentioned herein are the possession of their respective owners and McGraw-Hill Education makes no claim of ownership by the mention of products that contain these marks.
    [Show full text]
  • Scientists Prove Bioengineered Uteri Support Pregnancy 29 June 2020
    Scientists prove bioengineered uteri support pregnancy 29 June 2020 regenerative medicine and a number of the basic principles of tissue engineering and regenerative medicine were first developed at the institute. Their strategy to bioengineer functional tissues using a patient's own cells seeded onto biodegradable scaffolds has been effectively explored in preclinical studies and applied successfully in human patients to restore function in tubular and in hollow non-tubular organs. Regenerative medicine and tissue engineering technologies have emerged as an attractive option for overcoming donor organ A CT image of a bioengineered rabbit uterus with a shortages and other limitations of transplantation fetus, proving the organ supported fertilization, fetal from donors. The scientists used the same development. Credit: Wake Forest Institute for bioengineering strategy to engineer the uterus, a Regenerative Medicine (WFIRM) more complex organ with higher functional requirements involving support of embryo implantation and fetal development. In new research from the Wake Forest Institute for For this study, rabbits were randomly assigned to Regenerative Medicine (WFIRM), scientists have four groups: (1) a tissue-engineered uteri group that shown that bioengineered uteri supported received a cell-seeded scaffold using the animals' fertilization, fetal development, and live birth with own cells; (2) a non-seeded scaffold group, that normal offspring. With further development, this received a polymer scaffold only; (3) a subtotal approach may someday provide a regenerative uterine excision-only control group, where the medicine solution for women with the inability to subtotal excision was repaired by suturing and (4) a get pregnant due to uterine dysfunctional infertility normal control group, where animals underwent a sham laparotomy.
    [Show full text]
  • Ranking System.Xlsx
    Crew Rankings (As of August 1st 2009) New Rank Old Rank Change Crew Name Average Time 1 1 0 FCRCC 1:57.62 2 2 0 OHDBC Mayfair Predators 1:59.09 3 3 0 Dragon Beasts 1:59.18 4 On S'en Calisse 1:59.25 561ADBC - CSDC 2:00.26 6 0 Kai Ikaika Paddling Club 2:00.73 7 5 -2 SCC Team Chiro 2:01.28 8 10 2 OHDBC Hydrophobic Dragons 2:01.90 9 0 Dragon Hearts Magnum 2:02.59 10 23 13 Big Fish 2:02.77 11 0 Laoyam Eagles 2:02.99 12 11 -1 Verdun Adrenaline 2:03.22 13 0 Sudden Impact Black 2:03.37 14 12 -2 Hanalei 2:03.57 15 14 -1 Scotia Rouge 2:03.92 16 13 -3 Piranhas Dragon Boat Club 2:04.13 17 17 0 U of T New College New Dragons 2:04.25 18 0 FCRCC Women 2:04.48 19 20 1 Team Chaos 2:04.84 20 0 Masters of D'Zone 2:04.96 21 19 -2 Manayunk Mixed I 2:05.00 22 21 -1 Jetstart 2:05.04 23 25 2 Collingwood DBCC Sidelaunchers 2:05.76 24 29 5 Mojos Reloaded 2:05.95 25 35 10 The Saints 2:06.01 26 16 -10 OHDBC Hammerheads 2:06.08 27 0 Portland Firedragons 2:06.11 28 0 Anniemaniacs 2:06.14 29 31 2 MDBC Adrenaline-HRV 2:06.22 30 0 Without Warning 2:06.27 31 HydraHeads 2:06.33 32 40 8 Montreal Mix 2:06.47 33 56 23 PDBC Heat 2:06.50 34 36 2 The Blades 2:06.50 35 38 3 DCH DVP 2:06.56 36 0 San Francisco Dragon Warriors 2:06.60 37 0 Victoria College Paddling Club 2:06.66 38 52 14 MOFO''s 2:06.68 39 0 Philadelphia Police Boat Teams 2:06.75 40 33 -7 TECO Tan Anou Black 2:06.78 41 41 0 3R Dragon - Mixed 2:07.19 42 37 -5 TECO Tan Anou Red 2:07.20 43 49 6 University Elite Force 2:07.27 44 39 -5 Mayfair Warriors 2:07.39 45 51 6 Hydroblades 2:07.39 46 24 -22 PDBC 2:07.79 47 0 UC
    [Show full text]
  • Uehling Lectures
    2009 U Nonprofit Organization US Postage PAID Madison, Wisconsin EHLING Permit No. 658 OCPD in Medicine and Public Health 2701 International Lane, #208 Madison, WI 53704-3126 alem, NC alem, S Winston- chool of Medicine of chool S niversity U Foreset Wake and Public Health Health Public and Continuing Professional Development in Medicine Medicine in Development Professional Continuing egenerative Medicine egenerative R for Institute Director, Public Health, Department of Urology, and Office of of Office and Urology, of Department Health, Public rology rology U of Department Chairman, & Professor chool of Medicine and and Medicine of chool S Wisconsin of niversity U Anthony Atala, MD Atala, Anthony : Y B D RE O S SPON tephen Y. Nakada, MD Nakada, Y. tephen S R: O T C RE I D URSE O C , W , M ISCONSIN ADISON E E CATION U D TIVE U XEC C F OR F ENTER NO U L 6, 2009 6, N , F L U 2009 OVEMBER RIDAY RER U ECT EHLING L ECT 2009 UEHLING LECT U RES State of the Art Regenerative Dr. David T. Uehling was born and raised outside Chicago, and completed his urology training at Northwestern. Following a Medicine successful stint as a fellow at Chicago Children's Memorial Hospital, he joined the and staff at the University of Wisconsin in 1965. Clinically, Dr. Uehling developed a statewide Update in Pediatric Urology practice in pediatric urology, and has served the children of Wisconsin admirably for 40 U years. NOVEMBER 6, 2009 Throughout his career, Dr. Uehling distinguished himself in research, with FL U NO CENTER FOR EXEC U TIVE ED U CATION REScontinuous NIH funding in the treatment of urinary tract infections.
    [Show full text]
  • Case Studies on Innovation
    I N N O V A A T I O N 1 www.ibscdc.org ITC’s E-Choupal: A Mirage of the American studios declared in May 2007 Immelt charted his own leadership style Poor? that it had obtained the rights for and brought about a cultural revolution in developing a theme park based on the GE. Expectations were high and the E-Choupal is a novel initiative of ITC extremely successful character of the challenges were many. Immelt had to face Limited (ITC), an Indian conglomerate, popular culture Harry Potter in US, UK several challenges. He had to provide to improve its marketing channel in and all over the world. Walt Disney parks leadership and lend vision to a large, diverse agriculture. It has its roots in Project and resorts have also tried to get the rights conglomerate like GE in the post 9/11 Symphony – a pilot project launched in for Harry Potter theme park but failed to volatile global business scenario. He also 1999 to organise ITC’s agri business. The strike a deal with the creator of the Harry had to shift the company’s focus towards business model was designed to Potter character, J.K. Rowling. Universal innovation and customer centricity in accommodate farmers, intermediaries in and Disney have been competing in the addition to posting continued growth in a the traditional model and the company entertainment industry for many years, and sluggish economy. The case study discusses through information technology. The main Walt Disney had been a leader in theme Immelt’s innovation and customer centric objective of e-Choupal is dissemination and parks.
    [Show full text]
  • From Theleague
    LINES from the League The Student and Alumni Magazine of the Art Students League of New York Spring 2014 Letter from the Executive Director here has always been a welcoming spirit at the League. Those with an affinity for art know that they are with like-minded people who share T their goals and desires to master their mediums. In such a supportive environment, many of our students choose to remain and study years after first enrolling. In this regard, we are as much a community as we are a school. This is the nature of the League: there are as many reasons to attend the League as there are attending students. The Board and administration recognize the League’s primary mission of providing a program and setting that supports the individual pursuit of art. The outgrowth of our 140-year history is nothing short of staggering; more promi- nent artists studied at the League than in any other institution. The same holds true for our illustrious faculty. League members who credit the League with providing them the most rewarding time of their lives continue to support us through gifts and bequests. We continue to be a sanctuary for artistic discourse and discovery where students learn that there are no limits to what they can achieve through dedication and the practice of making art. We honor those who have shown such dedication. In this issue of Lines, we profile individuals such as instructor Bruce Dorfman, celebrating fifty years of teaching at the League, and artist Eleanor Adam, who came to the League after the death of her son Alex to learn art and rediscover her place in the world.
    [Show full text]
  • Anthony Atala, M.D
    Regenerative Cell Therapies: Making Safe and Effective Treatments Available to Patients Anthony Atala, M.D. Anthony Atala, MD, is the G. Link Professor and Director of the Wake Forest Institute for Regenerative Medicine, and the W. Boyce Professor and Chair of Urology. Dr. Atala is a practicing surgeon and a researcher in the area of regenerative medicine. Dr. Atala is Editor-in-Chief of three journals, including Stem Cells Translational Medicine, and Bioprinting. Dr. Atala was elected to the Institute of Medicine of the National Academies of Sciences, to the National Academy of Inventors as a Charter Fellow, and to the American Institute for Medical and Biological Engineering. Dr. Atala is a recipient of the US Congress funded Christopher Columbus Foundation Award, bestowed on a living American who is currently working on a discovery that will significantly affect society; the World Technology Award in Health and Medicine, for achieving significant and lasting progress; the Edison Science/Medical Award for innovation; the Smithsonian Ingenuity Award; the R&D Innovator of the Year Award, and the Fast Company World Changing Ideas Award for Bioprinting Tissue and Organs. Dr. Atala’s work was listed twice as Time Magazine’s top 5 medical breakthroughs of the year, and once as one of 5 discoveries that will change the future of organ transplants. He was named by Scientific American as one of the world’s most influential people in biotechnology, by U.S. News & World Report as one of 14 Pioneers of Medical Progress in the 21st Century, by Life Sciences Intellectual Property Review as one of the top key influencers in the life sciences intellectual property arena, and by Nature Biotechnology as one of the top 10 translational researchers in the world.
    [Show full text]